2026 By KarenLin August 6, 2026 0 Comments NuGen Announces Non-Binding LOI to Acquire Sol-Millennium Canada Toronto, Ontario – August 6, 2026 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company“) is pleased to announce it has entered a non-binding letter of intent (“LOI“) with Sol-Millennium Medical HK »
2026 By KarenLin July 29, 2026 0 Comments NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms Toronto, Ontario, July 27, 2026 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company“), a leader in needle-free drug delivery, today announced the filing of two additional patent applications supporting its current patent portfolio.»
2026 By KarenLin May 28, 2026 0 Comments NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance TORONTO, Ontario – May 28th , 2026 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle »
2026 By KarenLin March 26, 2026 0 Comments NuGen Files Patent for Ready to Fill COP/COC Needle Free Injection Nozzle, Advancing Prefilled Nozzle Technology NuGen Files Patent for Ready to Fill COP/COC Needle Free Injection Nozzle, Advancing Prefilled Nozzle Technology TORONTO, Ontario – March 25, 2026 – NuGen Medical Devices Inc. (“NuGen”), a leader in needle‑free drug delivery, today announced the filing »
2026 By KarenLin January 23, 2026 0 Comments NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress TORONTO, Ontario – January 16, 2026 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free subcutaneous drug-delivery »
